Skip to content

Randi D. Tomasulo, M.D.

NPI 1508980574ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Norwalk, CT

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Norwalk, Connecticut, licensed in CT, with an NPI issued in March 2007. Part D covered 137 prescriptions written in 2024. Novo Nordisk Inc was the largest of 4 companies reporting payments in 2025, $427.85 in all, mostly food and beverage.

Overview

NPI1508980574
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMar 16, 2007
Last updated in NPPESOct 29, 2014

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (CT)

Part D prescriptions in 2024

Prescriptions (claims)137 · 245 30-day fills
Patients13
Total drug cost$77,777

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$427.85 · 8 payments from 4 companies
  • 2024$114.67 · 6 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$230.965
Intuitive Surgical, Inc.$97.901
Amgen Inc.$83.781
Lilly USA, LLC$15.211

What the 2025 payments were for

  • Food and Beverage$427.85 · 8 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Norwalk

All endocrinologists in Connecticut